国际眼科杂志
國際眼科雜誌
국제안과잡지
International Eye Science
2015年
10期
1766-1768
,共3页
新生血管性青光眼%小梁切除术%睫状体冷凝术%眼压
新生血管性青光眼%小樑切除術%睫狀體冷凝術%眼壓
신생혈관성청광안%소량절제술%첩상체냉응술%안압
neovascular glaucoma%trabeculectomy%cyclocryotherapy%intraocular pressure
目的：观察玻璃体腔注射bevacizumab联合复合式小梁切除术治疗新生血管性青光眼的临床疗效。<br> 方法：选取2011-02/2013-09间在我院接受治疗的46例晚期NVG患者。分为两组,每组23例,A组为观察组,行玻璃体腔注射bevacizumab联合复合式小梁切除术, B组为对照组,给睫状体冷凝术治疗。术后对两组患者视力、眼压、虹膜新生血管、术后并发症进行对比观察,随访12 mo。<br> 结果：两组术后眼压均较术前下降,A组术后眼压水平低于B组,差异有统计学意义(P<0.05),A组治疗成功19例(83%), B组治疗成功12例(52%),差异有统计学意义(字2=4.847,P=0.028)。<br> 结论：玻璃体腔注射bevacizumab联合复合式小梁切除术治疗NVG能够有效控制眼压,成功率较高。
目的：觀察玻璃體腔註射bevacizumab聯閤複閤式小樑切除術治療新生血管性青光眼的臨床療效。<br> 方法：選取2011-02/2013-09間在我院接受治療的46例晚期NVG患者。分為兩組,每組23例,A組為觀察組,行玻璃體腔註射bevacizumab聯閤複閤式小樑切除術, B組為對照組,給睫狀體冷凝術治療。術後對兩組患者視力、眼壓、虹膜新生血管、術後併髮癥進行對比觀察,隨訪12 mo。<br> 結果：兩組術後眼壓均較術前下降,A組術後眼壓水平低于B組,差異有統計學意義(P<0.05),A組治療成功19例(83%), B組治療成功12例(52%),差異有統計學意義(字2=4.847,P=0.028)。<br> 結論：玻璃體腔註射bevacizumab聯閤複閤式小樑切除術治療NVG能夠有效控製眼壓,成功率較高。
목적：관찰파리체강주사bevacizumab연합복합식소량절제술치료신생혈관성청광안적림상료효。<br> 방법：선취2011-02/2013-09간재아원접수치료적46례만기NVG환자。분위량조,매조23례,A조위관찰조,행파리체강주사bevacizumab연합복합식소량절제술, B조위대조조,급첩상체냉응술치료。술후대량조환자시력、안압、홍막신생혈관、술후병발증진행대비관찰,수방12 mo。<br> 결과：량조술후안압균교술전하강,A조술후안압수평저우B조,차이유통계학의의(P<0.05),A조치료성공19례(83%), B조치료성공12례(52%),차이유통계학의의(자2=4.847,P=0.028)。<br> 결론：파리체강주사bevacizumab연합복합식소량절제술치료NVG능구유효공제안압,성공솔교고。
AIM: To observe the clinical effects of intravitreal injection of bevacizumab combined with complex trabeculectomy for neovascular glaucoma ( NVG) . <br> METHODS:Totally 46 patients with advanced NVG from February 2011 to September 2013 in our hospital were selected and divided into observation group ( group A ) and control group ( group B ) , 23 cases in each group. Patients in group A were treated with intravitreal injection of bevacizumab combined with complex trabeculectomy. Patients in group B were treated with cyclocryotherapy. The visual acuity, intraocular pressure ( IOP ) , degeneration of iris neovascularization and postoperative complications of the two groups were observed. All the patients were followed up for 12mo. <br> RESULTS: The postoperative IOP was decreased significantly compared with preoperative in the two groups, and the IOP level of group A was lower than that of group B, the difference was statistically significant ( P<0. 05). Nineteen cases (83%) were treated successfully in group A, and 12 cases ( 52%) in group B, the difference was statistically significant (χ2=4. 847, P=0. 028). <br> CONCLUSION: Intravitreal injection of bevacizumab combined with complex trabeculectomy for neovascular glaucoma can effectively control IOP, and has higher successful rate.
